180 related articles for article (PubMed ID: 31378902)
1. LncRNA RUSC1-AS1 promotes the proliferation of breast cancer cells by epigenetic silence of KLF2 and CDKN1A.
Hu CC; Liang YW; Hu JL; Liu LF; Liang JW; Wang R
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6602-6611. PubMed ID: 31378902
[TBL] [Abstract][Full Text] [Related]
2. Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
Ma Z; Peng P; Zhou J; Hui B; Ji H; Wang J; Wang K
Cell Physiol Biochem; 2018; 46(6):2197-2214. PubMed ID: 29734178
[TBL] [Abstract][Full Text] [Related]
3. TATDN1 promotes the development and progression of breast cancer by targeting microRNA-140-3p.
Yu XY; Tian JR; Yang D; Tan HR
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5293-5300. PubMed ID: 31298381
[TBL] [Abstract][Full Text] [Related]
4. RUSC1-AS1 promotes the malignant progression of breast cancer depending on the regulation of the miR-326/XRCC5 pathway.
Ayoufu A; Paierhati P; Qiao L; Zhang N; Abudukeremu M
Thorac Cancer; 2023 Aug; 14(24):2504-2514. PubMed ID: 37429610
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA
Guo Q; Zhang Q; Lu L; Xu Y
Cell Cycle; 2020 May; 19(10):1222-1235. PubMed ID: 32264732
[TBL] [Abstract][Full Text] [Related]
6. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
Ma D; Chen C; Wu J; Wang H; Wu D
Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA AFAP1-AS1 promotes proliferation and migration of gastric cancer by downregulating KLF2.
Yuan XH; Li J; Cao Y; Jie ZG; Zeng YF
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):673-680. PubMed ID: 32016968
[TBL] [Abstract][Full Text] [Related]
8. LncRNA DLEU1/microRNA-300/RAB22A axis regulates migration and invasion of breast cancer cells.
Wang C; Xie XX; Li WJ; Jiang DQ
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10410-10421. PubMed ID: 31841195
[TBL] [Abstract][Full Text] [Related]
9. LncRNA RUSC1-AS1 promotes the proliferation of hepatocellular carcinoma cells through modulating NOTCH signaling.
Chen YA; Cheng L; Zhang Y; Peng L; Yang HG
Neoplasma; 2020 Nov; 67(6):1204-1213. PubMed ID: 32701359
[TBL] [Abstract][Full Text] [Related]
10. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
Li GH; Yu JH; Yang B; Gong FC; Zhang KW
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA HOXD-AS1 induces epithelial-mesenchymal transition in breast cancer by acting as a competing endogenous RNA of miR-421.
Li Y; Han X; Li Q; Wang C; Lou Z; Wang X
J Cell Biochem; 2019 Jun; 120(6):10633-10642. PubMed ID: 30730081
[TBL] [Abstract][Full Text] [Related]
12. KLF5-induced lncRNA IGFL2-AS1 promotes basal-like breast cancer cell growth and survival by upregulating the expression of IGFL1.
Wang H; Shi Y; Chen CH; Wen Y; Zhou Z; Yang C; Sun J; Du G; Wu J; Mao X; Liu R; Chen C
Cancer Lett; 2021 Sep; 515():49-62. PubMed ID: 34052325
[TBL] [Abstract][Full Text] [Related]
13. DUXAP8, a pseudogene derived lncRNA, promotes growth of pancreatic carcinoma cells by epigenetically silencing CDKN1A and KLF2.
Lian Y; Yang J; Lian Y; Xiao C; Hu X; Xu H
Cancer Commun (Lond); 2018 Oct; 38(1):64. PubMed ID: 30367681
[TBL] [Abstract][Full Text] [Related]
14. LncRNA GNAS-AS1 facilitates ER+ breast cancer cells progression by promoting M2 macrophage polarization via regulating miR-433-3p/GATA3 axis.
Liu SQ; Zhou ZY; Dong X; Guo L; Zhang KJ
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32538432
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.
Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K
J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205
[TBL] [Abstract][Full Text] [Related]
16. LncRNA RUSC1-AS1 promotes osteosarcoma progression through regulating the miR-340-5p and PI3K/AKT pathway.
Tong CJ; Deng QC; Ou DJ; Long X; Liu H; Huang K
Aging (Albany NY); 2021 May; 13(16):20116-20130. PubMed ID: 34048366
[TBL] [Abstract][Full Text] [Related]
17. LncRNA AFAP1-AS1 promotes proliferation ability and invasiveness of bladder cancer cells.
Gui JQ; Zhang C; Yang HB; Yu YW; Cui MR; Wang WS
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8747-8755. PubMed ID: 32964963
[TBL] [Abstract][Full Text] [Related]
18. ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA.
Luo N; Zhang K; Li X; Hu Y
J Cell Biochem; 2020 Oct; 121(10):4176-4187. PubMed ID: 31922280
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of lncRNA FOXD2-AS1 Inhibits Proliferation, Migration, and Drug Resistance of Breast Cancer Cells.
Nong Q; Yu S; Hu H; Hu X
Comput Math Methods Med; 2021; 2021():9674761. PubMed ID: 34873418
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non-small cell lung cancer cell proliferation by epigenetically repressing p21 expression.
Yin D; Lu X; Su J; He X; De W; Yang J; Li W; Han L; Zhang E
Mol Cancer; 2018 May; 17(1):92. PubMed ID: 29793547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
